Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$1.91B |
| 2 |
United Parcel Service
UPS
|
+$1.86B |
| 3 |
Chevron
CVX
|
+$1.72B |
| 4 |
Blackstone
BX
|
+$904M |
| 5 |
Ford
F
|
+$722M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$1.64B |
| 2 |
Prudential Financial
PRU
|
+$553M |
| 3 |
Genuine Parts
GPC
|
+$543M |
| 4 |
Cummins
CMI
|
+$538M |
| 5 |
Hartford Financial Services
HIG
|
+$376M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.33% |
| 2 | Healthcare | 13.03% |
| 3 | Financials | 11.86% |
| 4 | Consumer Discretionary | 9.84% |
| 5 | Industrials | 9.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CSR
1751
Centerspace
CSR
$928M
| $12.8M | ﹤0.01% |
233,677
+5,226
| +2% | +$322K |
|
1752
Medifast
MED
$110M
| $12.7M | ﹤0.01% |
122,873
+9,347
| +8% | +$1.04M |
|
1753
Usana Health Sciences
USNA
$417M
| $12.7M | ﹤0.01% |
202,138
+12,701
| +7% | +$758K |
|
1754
Freshworks
FRSH
$3.3B
| $12.7M | ﹤0.01% |
827,463
-8,161
| -1% | -$124K |
|
1755
TriCo Bancshares
TCBK
$1.86B
| $12.7M | ﹤0.01% |
305,542
+1,576
| +0.5% | +$76K |
|
1756
RadNet
RDNT
$5.3B
| $12.7M | ﹤0.01% |
507,544
+14,967
| +3% | +$325K |
|
1757
Eagle Bancorp
EGBN
$846M
| $12.7M | ﹤0.01% |
379,085
+6,095
| +2% | +$260K |
|
1758
CNA Financial
CNA
$14.5B
| $12.6M | ﹤0.01% |
322,312
+12,098
| +4% | +$507K |
|
1759
Celldex Therapeutics
CLDX
$2.98B
| $12.5M | ﹤0.01% |
346,723
-1,530
| -0.4% | -$66K |
|
1760
Gray Television
GTN
$427M
| $12.5M | ﹤0.01% |
1,430,236
+122,720
| +9% | +$1.37M |
|
1761
Koppers
KOP
$963M
| $12.4M | ﹤0.01% |
355,178
+9,646
| +3% | +$321K |
|
1762
Phreesia
PHR
$692M
| $12.4M | ﹤0.01% |
384,581
+539
| +0.1% | +$19K |
|
|
SLCA
1763
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $12.4M | ﹤0.01% |
1,038,675
+135,244
| +15% | +$1.61M |
|
1764
Remitly
RELY
$5.08B
| $12.4M | ﹤0.01% |
730,265
+3,430
| +0.5% | +$46.6K |
|
|
CIM
1765
Chimera Investment
CIM
$1.06B
| $12.4M | ﹤0.01% |
731,491
+20,907
| +3% | +$400K |
|
1766
Perdoceo Education
PRDO
$2.03B
| $12.4M | ﹤0.01% |
921,204
-16,307
| -2% | -$228K |
|
1767
Amphastar Pharmaceuticals
AMPH
$882M
| $12.4M | ﹤0.01% |
329,913
+3,125
| +1% | +$102K |
|
1768
Pathward Financial
CASH
$1.91B
| $12.4M | ﹤0.01% |
297,904
+911
| +0.3% | +$42.9K |
|
|
KYNB
1769
Kyntra Bio
KYNB
$28.3M
| $12.4M | ﹤0.01% |
26,489
-250
| -0.9% | -$132K |
|
|
HCP
1770
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
| $12.3M | ﹤0.01% |
421,559
+39,573
| +10% | +$1.18M |
|
|
INVX
1771
Innovex International
INVX
$1.99B
| $12.3M | ﹤0.01% |
430,364
-2,510
| -0.6% | -$74.4K |
|
1772
Reynolds Consumer Products
REYN
$5.28B
| $12.3M | ﹤0.01% |
448,409
+23,388
| +6% | +$661K |
|
1773
Ecovyst
ECVT
$1.32B
| $12.3M | ﹤0.01% |
1,114,745
+136,145
| +14% | +$1.41M |
|
|
NXRT
1774
NexPoint Residential Trust
NXRT
$667M
| $12.3M | ﹤0.01% |
281,940
+2,896
| +1% | +$133K |
|
|
NXGN
1775
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $12.3M | ﹤0.01% |
705,404
+22,038
| +3% | +$396K |
|
Similar funds
Charles Schwab's Q1 2023 Portfolio in Review
As of Q1 2023, Charles Schwab held 3,654 positions worth $329B, up 6% from $310B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q1 2023 filing shows 108 new, 2,088 increased, 988 reduced and 104 closed positions. Its largest new stake was GE HealthCare: 1,875,333 shares worth $154M. The largest sale was IBM, an estimated $1.64B.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
- Charles Schwab's largest Q1 2023 buy was GE HealthCare: 1,875,333 shares worth $154M.
- Charles Schwab added most to AbbVie in Q1 2023, an estimated $1.91B increase.
- Charles Schwab's biggest Q1 2023 reduction was IBM, cutting an estimated $1.64B.
- Charles Schwab fully exited STORE Capital Corporation in Q1 2023, selling an estimated $100M.
- Charles Schwab's ten largest holdings make up 17% of its $329B portfolio in Q1 2023.
- Charles Schwab opened 108 new positions and closed 104 in Q1 2023.
- Charles Schwab's portfolio value rose 6% quarter-over-quarter to $329B.
Based on Charles Schwab's 13F filing for Q1 2023, filed 12 May 2023.